BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36372901)

  • 1. Role of postoperative chemoradiotherapy in head and neck cancer without positive margins or extracapsular extension: a propensity score-matching analysis.
    Liu ZQ; OuYang PY; Zhang BY; Chen EN; Xiao SM; Yang SS; Yang ZY; Xie FY
    Radiat Oncol; 2022 Nov; 17(1):180. PubMed ID: 36372901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.
    Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM
    Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy.
    Moretti L; Yu DS; Chen H; Carbone DP; Johnson DH; Keedy VL; Putnam JB; Sandler AB; Shyr Y; Lu B
    Oncologist; 2009 Nov; 14(11):1106-15. PubMed ID: 19897534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy's efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients.
    Zhang B; Zhao L; Yuan Z; Pang Q; Wang P
    Onco Targets Ther; 2016; 9():6161-6169. PubMed ID: 27785064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
    Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations.
    Deng Q; Wang H; Xiu W; Tian X; Gong Y
    Jpn J Radiol; 2023 May; 41(5):551-560. PubMed ID: 36484979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative Concurrent Chemoradiotherapy versus Postoperative Radiotherapy Alone for Larynx Squamous Cell Carcinoma Patients with Lymphovascular Invasion: A Propensity Score Matching Study.
    Yu S; Zhu Y; Shi X; Hu K; Bai C; Diao W; Zhu X; Gao Z; Chen X
    Cancer Manag Res; 2020; 12():4063-4071. PubMed ID: 32581580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Comer JC; King RB; Harris AB; Hitchcock KE; Mendenhall WM; Bates JE; Dziegielewski PT
    Oral Oncol; 2022 Apr; 127():105767. PubMed ID: 35217400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes following observation, post-operative radiation therapy, or post-operative chemoradiation for HPV-associated oropharyngeal squamous cell carcinomas.
    Singh R; Song S
    Oral Oncol; 2023 Nov; 146():106493. PubMed ID: 37713768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification.
    Yoshida EJ; Luu M; David JM; Kim S; Mita A; Scher K; Shiao SL; Tighiouart M; Ho AS; Zumsteg ZS
    Head Neck; 2018 Jun; 40(6):1228-1236. PubMed ID: 29417700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
    Ni W; Yu S; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D; Zhao J; Gao Y
    Oncologist; 2021 Dec; 26(12):e2151-e2160. PubMed ID: 34309117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of care and outcomes of adjuvant therapy for high-risk head and neck cancer after surgery.
    Osborn VW; Givi B; Rineer J; Roden D; Sheth N; Lederman A; Katsoulakis E; Hu K; Schreiber D
    Head Neck; 2018 Jun; 40(6):1254-1262. PubMed ID: 29451961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
    Li D; Li W; Pang Y; Xu L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.
    Wei W; Zhou J; Zhang Q; Liao DH; Liu QD; Zhong BL; Liang ZB; Zhang YC; Jiang R; Liu GY; Xu CY; Li Zhou H; Zhu SY; Yang N; Jiang W; Liu ZG
    Cancer Med; 2020 Apr; 9(8):2820-2832. PubMed ID: 32100444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of pathological complete remission after preoperative irradiation in patients with locally advanced head and neck squamous cell carcinoma: re-analysis of a phase 3 clinical study.
    Wang K; Yi J; Huang X; Qu Y; Luo J; Xiao J; Zhang S; Tang Y; Liu W; Xu G; Gao L; Xu Z; Liu S; Wang X
    Radiat Oncol; 2019 Dec; 14(1):225. PubMed ID: 31831042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.